Form 8-K - Current report:
SEC Accession No. 0001297184-23-000026
Filing Date
2023-03-10
Accepted
2023-03-10 16:08:52
Documents
12
Period of Report
2023-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K amph-20230308x8k.htm   iXBRL 8-K 51521
  Complete submission text file 0001297184-23-000026.txt   170241

Data Files

Seq Description Document Type Size
2 EX-101.SCH amph-20230308.xsd EX-101.SCH 3363
3 EX-101.LAB amph-20230308_lab.xml EX-101.LAB 15361
4 EX-101.PRE amph-20230308_pre.xml EX-101.PRE 10385
6 EXTRACTED XBRL INSTANCE DOCUMENT amph-20230308x8k_htm.xml XML 4635
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 23723683
SIC: 2834 Pharmaceutical Preparations